These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35143051)

  • 1. How do I: Evaluate the safety and legitimacy of unproven cellular therapies?
    Guleria I; de Los Angeles Muñiz M; Wilgo M; Bapat A; Cui W; Hsu YS; Jeyaraman M; Muthu S; Rodriguez F; Fesnak A; Celluzzi C; Sesok-Pizzini D; Reich-Slotky R; Spitzer T
    Transfusion; 2022 Mar; 62(3):518-532. PubMed ID: 35143051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The roles and responsibilities of physicians in patients' decisions about unproven stem cell therapies.
    Levine AD; Wolf LE
    J Law Med Ethics; 2012; 40(1):122-34. PubMed ID: 22458467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International Society for Cell & Gene Therapy Position Paper: Key considerations to support evidence-based cell and gene therapies and oppose marketing of unproven products.
    Ikonomou L; Cuende N; Forte M; Grilley BJ; Levine AD; Munsie M; Rasko JEJ; Turner L; Bidkhori HR; Ciccocioppo R; Grignon F; Srivastava A; Weiss DJ; Zettler P; Levine BL;
    Cytotherapy; 2023 Sep; 25(9):920-929. PubMed ID: 37517865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone Marrow Concentrate (BMC) Therapy in Musculoskeletal Disorders: Evidence-Based Policy Position Statement of American Society of Interventional Pain Physicians (ASIPP).
    Manchikanti L; Centeno CJ; Atluri S; Albers SL; Shapiro S; Malanga GA; Abd-Elsayed A; Jerome M; Hirsch JA; Kaye AD; Aydin SM; Beall D; Buford D; Borg-Stein J; Buenaventura RM; Cabaret JA; Calodney AK; Candido KD; Cartier C; Latchaw R; Diwan S; Dodson E; Fausel Z; Fredericson M; Gharibo CG; Gupta M; Kaye AM; Knezevic NN; Kosanovic R; Lucas M; Manchikanti MV; Mason RA; Mautner K; Murala S; Navani A; Pampati V; Pastoriza S; Pasupuleti R; Philip C; Sanapati MR; Sand T; Shah RV; Soin A; Stemper I; Wargo BW; Hernigou P
    Pain Physician; 2020 Mar; 23(2):E85-E131. PubMed ID: 32214287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The evolution and ongoing challenge of unproven cell-based interventions.
    Brinsfield TN; Pinson NR; Levine AD
    Stem Cells Transl Med; 2024 Sep; 13(9):851-858. PubMed ID: 39045646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The involvement of Canadian physicians in promoting and providing unproven and unapproved stem cell interventions.
    Ogbogu U; Du J; Koukio Y
    BMC Med Ethics; 2018 May; 19(1):32. PubMed ID: 29716594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unproven stem cell-based interventions & physicians' professional obligations; a qualitative study with medical regulatory authorities in Canada.
    Zarzeczny A; Clark M
    BMC Med Ethics; 2014 Oct; 15():75. PubMed ID: 25315976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unproven cell interventions in Poland and the exploitation of European Union law on advanced therapy medicinal products.
    Dulak J; Pecyna M
    Stem Cell Reports; 2023 Aug; 18(8):1610-1620. PubMed ID: 37390824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Infodemic of Misinformation on Stem Cell Therapy Among the Population of Saudi Arabia: A Cross-Sectional Study.
    Aboalola D; Badraiq H; Alsiary R; Zakri S; Aboulola N; Haneef L; Malibari D; Baadhaim M; Alsayegh K
    Front Med (Lausanne); 2022; 9():789695. PubMed ID: 35308548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overcoming challenges to initiating cell therapy clinical trials in rapidly developing countries: India as a model.
    Viswanathan S; Rao M; Keating A; Srivastava A
    Stem Cells Transl Med; 2013 Aug; 2(8):607-13. PubMed ID: 23836804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proceedings of the signature series symposium "cellular therapies for orthopaedics and musculoskeletal disease proven and unproven therapies-promise, facts and fantasy," international society for cellular therapies, montreal, canada, may 2, 2018.
    Piuzzi NS; Dominici M; Long M; Pascual-Garrido C; Rodeo S; Huard J; Guicheux J; McFarland R; Goodrich LR; Maddens S; Robey PG; Bauer TW; Barrett J; Barry F; Karli D; Chu CR; Weiss DJ; Martin I; Jorgensen C; Muschler GF
    Cytotherapy; 2018 Nov; 20(11):1381-1400. PubMed ID: 30316562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic Mesenchymal Stem Cell-Based Treatment Legislation in Latin America: The Need for Standardization in a Medical Tourism Context.
    Orozco-Solares TE; León-Moreno LC; Rojas-Rizo A; Manguart-Páez K; Caplan AI
    Stem Cells Dev; 2022 Apr; 31(7-8):143-162. PubMed ID: 35216516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concise Review: A Comprehensive Analysis of Reported Adverse Events in Patients Receiving Unproven Stem Cell-Based Interventions.
    Bauer G; Elsallab M; Abou-El-Enein M
    Stem Cells Transl Med; 2018 Sep; 7(9):676-685. PubMed ID: 30063299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Untested, unproven, and unethical: the promotion and provision of autologous stem cell therapies in Australia.
    McLean AK; Stewart C; Kerridge I
    Stem Cell Res Ther; 2015 Feb; 6(1):33. PubMed ID: 25689404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Administrative and research policies required to bring cellular therapies from the research laboratory to the patient's bedside.
    Yim R
    Transfusion; 2005 Oct; 45(4 Suppl):144S-58S. PubMed ID: 16181400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Academic physician specialists' views toward the unproven stem cell intervention industry: areas of common ground and divergence.
    Smith C; Crowley A; Munsie M; DeMartino ES; Staff NP; Shapiro S; Master Z
    Cytotherapy; 2021 Apr; 23(4):348-356. PubMed ID: 33563545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular therapy injections in today's orthopedic market: A social media analysis.
    Ramkumar PN; Navarro SM; Haeberle HS; Chughtai M; Demetriades C; Piuzzi NS; Mont MA; Bauer TW; Muschler GF
    Cytotherapy; 2017 Dec; 19(12):1392-1399. PubMed ID: 28916228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory and policy tools to address unproven stem cell interventions in Canada: the need for action.
    Caulfield T; Murdoch B
    BMC Med Ethics; 2019 Aug; 20(1):51. PubMed ID: 31383026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Untested Stem Cell Treatments: An Analysis of Australia's Current Regulatory Regime.
    Cavasinni N; Foong P
    J Law Med; 2024 May; 31(1):105-121. PubMed ID: 38761392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.